Bicocca Open Archive

Logo unimib boa
CORTESI, PAOLO ANGELO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.902
EU - Europa 6.667
AS - Asia 3.492
SA - Sud America 315
AF - Africa 60
OC - Oceania 25
Continente sconosciuto - Info sul continente non disponibili 12
Totale 21.473
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.696
IT - Italia 1.643
SG - Singapore 1.455
RU - Federazione Russa 1.090
DE - Germania 964
CN - Cina 812
IE - Irlanda 667
SE - Svezia 663
HK - Hong Kong 642
UA - Ucraina 374
GB - Regno Unito 301
BR - Brasile 271
FR - Francia 257
CA - Canada 177
FI - Finlandia 158
ID - Indonesia 158
DK - Danimarca 146
AT - Austria 127
IN - India 98
NL - Olanda 89
TR - Turchia 86
VN - Vietnam 80
BE - Belgio 44
CH - Svizzera 32
IR - Iran 26
ES - Italia 21
ZA - Sudafrica 21
AU - Australia 20
CZ - Repubblica Ceca 19
KR - Corea 19
MX - Messico 19
AR - Argentina 14
PH - Filippine 13
PK - Pakistan 13
BD - Bangladesh 12
BG - Bulgaria 11
EU - Europa 11
RO - Romania 11
CL - Cile 9
JP - Giappone 9
NO - Norvegia 9
TW - Taiwan 9
PT - Portogallo 8
UZ - Uzbekistan 8
AE - Emirati Arabi Uniti 7
AL - Albania 7
IQ - Iraq 7
MA - Marocco 7
EC - Ecuador 6
KE - Kenya 6
PL - Polonia 6
VE - Venezuela 6
ET - Etiopia 5
GR - Grecia 5
NG - Nigeria 5
NZ - Nuova Zelanda 5
TH - Thailandia 5
AZ - Azerbaigian 4
CO - Colombia 4
GH - Ghana 4
MY - Malesia 4
DZ - Algeria 3
EG - Egitto 3
IL - Israele 3
LK - Sri Lanka 3
LT - Lituania 3
LU - Lussemburgo 3
OM - Oman 3
PE - Perù 3
SC - Seychelles 3
AM - Armenia 2
BZ - Belize 2
GE - Georgia 2
GT - Guatemala 2
JO - Giordania 2
KZ - Kazakistan 2
MD - Moldavia 2
MK - Macedonia 2
NI - Nicaragua 2
NP - Nepal 2
SA - Arabia Saudita 2
SO - Somalia 2
A1 - Anonimo 1
BH - Bahrain 1
DO - Repubblica Dominicana 1
GA - Gabon 1
HN - Honduras 1
HR - Croazia 1
HU - Ungheria 1
JM - Giamaica 1
KG - Kirghizistan 1
LA - Repubblica Popolare Democratica del Laos 1
LI - Liechtenstein 1
ME - Montenegro 1
MN - Mongolia 1
PY - Paraguay 1
SK - Slovacchia (Repubblica Slovacca) 1
UY - Uruguay 1
VG - Isole Vergini Britanniche 1
Totale 21.473
Salva come PNG Salva come JPEG
Città #
Ann Arbor 1.847
Singapore 887
Fairfield 858
Woodbridge 832
Chandler 727
Houston 662
Dublin 642
Hong Kong 632
Ashburn 595
Frankfurt am Main 589
Wilmington 559
Milan 465
Santa Clara 385
Jacksonville 380
Seattle 374
Dearborn 345
New York 333
Cambridge 280
Princeton 278
Nanjing 144
Jakarta 138
Altamura 128
Lawrence 124
Vienna 101
Shanghai 86
Helsinki 65
Beijing 64
San Diego 62
Lachine 60
Rome 58
Council Bluffs 53
London 53
Andover 51
Nanchang 47
Nuremberg 47
Moscow 45
Guangzhou 44
Dong Ket 43
Toronto 41
Boardman 40
Shenyang 40
Tianjin 36
Fremont 34
Ottawa 34
Brussels 33
Los Angeles 33
Jinan 31
Hebei 28
Jiaxing 28
Lissone 27
Lappeenranta 26
Munich 26
Falls Church 25
Zhengzhou 25
Changsha 24
Redmond 24
Bologna 23
Hangzhou 22
Verona 22
Ningbo 21
São Paulo 21
Washington 21
Paris 20
Pune 20
Chicago 19
Turin 18
Kocaeli 17
San Jose 17
Kunming 16
Mountain View 16
Norwalk 16
Parma 15
Boston 14
Legnano 13
Taizhou 13
Düsseldorf 12
Florence 12
Hefei 12
Monza 12
Bergamo 11
Naples 11
Palermo 11
Perugia 11
Rio de Janeiro 11
Bonndorf 10
Carate Brianza 10
Edmonton 10
Nürnberg 10
San Mateo 10
Zurich 10
Dallas 9
Huizen 9
Montréal 9
Padova 9
Belo Horizonte 8
Brno 8
Madrid 8
Pavia 8
Phoenix 8
Prague 8
Totale 14.229
Salva come PNG Salva come JPEG
Nome #
Costs and effects of cardiovascular risk reclassification using the ankle-brachial index (ABI) in addition to the Framingham risk scoring in women 361
Global, regional, and national burden of neurological disorders, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 351
Clinical outcome indicators in chronic hepatitis B and C: A primer for value-based medicine in hepatology 318
Anti-inhibitor coagulant complex prophylaxis in hemophilia with inhibitors 309
Cost and Cost Effectiveness of Treatments for Psoriatic Arthritis: A Systematic Literature Review 293
Optimising the clinical strategy for autoimmune liver diseases: Principles of value-based medicine 260
Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 254
Trends in cardiovascular diseases burden and vascular risk factors in Italy: The Global Burden of Disease study 1990–2017 240
Trattamento con Sofosbuvir e Ribavirina nei pazienti hcv-positivi listati per il trapianto di fegato: un analisi di costo-efficacia 232
Value-based outcome indicators in the management of hepatocellular carcinoma: Clinical test in a large multicenter study (VBMH study) 215
P1169 : Outcome indicators in primary sclerosing cholangitis: Interim analysis of the value-based medicine in hepatology study 210
Outcome indicators in primary sclerosing cholangitis: Interim analysis of the value-based medicine in hepatology study 207
P0811 : Sofosbuvir-based direct-acting antivirals treatment for elderly chronic hepatitis C patients: A cost-effectiveness analysis 207
Generation and performance of value-based outcome indicators in liver disease: The multicenter V.B.M.H. study 206
The optimal timing of hepatitis C therapy in liver transplant-eligible patients: Cost-effectiveness analysis of new opportunities 200
Cost-Effectiveness and Budget Impact of Emicizumab Prophylaxis in Haemophilia A Patients with Inhibitors 199
Outcome indicators in liver cirrhosis: Application of value-based medicine in a large multicenter study (VBMH study) 197
Health Related Quality of Life in the Major Liver Conditions 196
Population and fertility by age and sex for 195 countries and territories, 1950–2017: a systematic analysis for the Global Burden of Disease Study 2017 196
Health related quality of life in chronic liver diseases 196
Outcome Indicators in Primary Sclerosing Cholangitis: Interim Analysis Of The Value-Based Medicine In Hepatology (VBMH) Study 195
Global, regional, and national burden of congenital heart disease, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 193
The impact of liver disease on the health-related quality of life 192
Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017 191
Characteristics of patients with Chronic Hepatitis C who have failed past treatment or who have never been treated: How much room left for Interferon? 189
Italy's health performance, 1990–2017: findings from the Global Burden of Disease Study 2017 189
Value-based outcome indicators in liver cirrhosis: validation in a large multicenter study (VBMH study) 188
Measurement of clinical outcomes and quality of life indicators as a new value-based approach to liver cirrhosis management 187
The Impact of Type of Liver Conditions on the Patients’ Health Related Quality of Life 185
Sustainability of the Italian National Health Service 185
Should new antiviral treatments be considered in elderly Chronic Hepatitis C patients? 182
Benefits in pain perception, ability function and health-related quality of life in patients with failed back surgery syndrome undergoing spinal cord stimulation in a clinical practice setting 182
Sacubitril/valsartan in heart failure with reduced ejection fraction: cost and effectiveness in the Italian context 181
Economic Burden of Urticaria Requiring Hospitalization: Analysis from an Administrative Database 180
Should Sofosbuvir-Based All-Oral Treatment Be Considered In Elderly Chronic Hepatitis C Patients? 179
Costs and effectiveness of influenza vaccination: A systematic review 179
PGI36 Relationship Between Clinical Severity and Health Related Quality of Life in Chronic Liver Diseases 178
Generation and Performance of Outcome Indicators in Liver Cirrhosis: The Value Based Medicine in Hepatology Study (V.B.M.H.) 178
COVID-19 outbreak impact on anticoagulants utilization: an interrupted time-series analysis using healthcare administrative databases 178
Sofosbuvir-based all-oral treatment for elderly chronic hepatitis C patients: A cost-effectiveness analysis 177
Global, regional, and national incidence, prevalence, and years lived with disability for 354 Diseases and Injuries for 195 countries and territories, 1990-2017: A systematic analysis for the Global Burden of Disease Study 2017 176
Measuring performance on the Healthcare Access and Quality Index for 195 countries and territories and selected subnational locations: a systematic analysis from the Global Burden of Disease Study 2016 174
A Comparison Between The Health-Related Quality Of Life Reported By The General Population And By Patients With Major Liver Diseases 174
The socioeconomic burden of patients affected by hemophilia with inhibitors 173
Il burden delle polmoniti: analisi dai database amministrativi (DENALI) della regione Lombardia. 172
Management of treatment-naïve chronic hepatitis C genotype 1 patients: A cost-effectiveness analysis of treatment options 172
The Burden of Severe Hypoglicaemias and Diabetes Ketoacidosis: A Population-Based Study 171
Direct-acting antivirals combination for elderly patients with chronic hepatitis C: A cost-effectiveness analysis 169
PGI31 Health Care Indicators to Measure Quality of Care in Patients with Liver Diseases 166
Models of The Impact of Major Liver Diseases on Eq-5d Visual Analogue Scale and Utility-Index: Convergences and Divergences 165
Economic Burden Of Stroke: Analysis From An Administrative Database 164
The Cost-Effectiveness Of Sofosbuvir And Ribavirin Treatment In Hcv-Infected Patients Listed For Liver Transplantation 163
Effective but costly: How to tackle difficult trade-offs in evaluating health improving technologies in liver diseases 162
A value-based approach to the management of patients with liver cirrhosis through the systematic measurement of clinical outcome and quality of life indicators 161
Value-based approach to hepatocellular carcinoma: outcome indicators tested in a large multicenter study (VBMH study) 158
Immune tolerance induction in patients with haemophilia a and inhibitors: Effectiveness and cost analysis in an European Cohort (The ITER Study) 158
Utilization of disease modifying agents in multiple sclerosis: from an Italian administrative database. 153
Management of chronic hepatitis C (Chc) genotype 1 treatment-naïve patients in an era of rising opportunities and costs: A cost-effectiveness analysis 153
Management of Chronic hepatitis C (CHC) Genotype 1 treatment-naive patients in an era of rising opportunities and costs - A cost-effectiveness analysis of treatment options 151
Impatto dei farmaci anti virali ad azione diretta sulla cura dei pazienti con epatite C: un approccio di value-based medicine 151
Liver transplantation for patients with acute-on-chronic liver failure (ACLF) in Europe: results of the ELITA/EF-CLIF collaborative study (ECLIS) 151
Epidemiology and Direct Health Care Costs of Diabetic Retinopathy: Results From a Population-Based Study 150
Cost-effectiveness analysis of pharmacokinetic-driven prophylaxis vs. standard prophylaxis in patients with severe haemophilia A 148
Epidemiologic And Economic Burden Attributable To Atrial Fibrillation From Administrative Data 146
Cost-effectiveness of Sofosbuvir plus Ledipasvir Antiviral Treatment for Elderly Patients with Chronic Hepatitis C Genotype 1 146
Health related quality of life norm data of the general population in Italy: Results using the EQ-5D-3L and EQ-5D-5L instruments 143
Global, regional, and national age-sex-specific mortality and life expectancy, 1950-2017: A systematic analysis for the Global Burden of Disease Study 2017 142
Use of health care administrative databases to estimate the burden of breast cancer. 141
The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 141
Incidence of inhibitors to recombinant factor VIII products – A meta-analysis of 1,852 previously untreated patients 140
Protective role of tacrolimus, deleterious role of age and comorbidities in liver transplant recipients with Covid-19: results from the ELITA/ELTR multi-center European study 140
Preferenze della popolazione italiana per gli stati di salute dell'EQ-5D 138
Delisting HCV-infected liver transplant candidates who improved after viral eradication: Outcome 2 years after delisting 138
Italian population-based values of EQ-5D health states 137
Use of health care administrative databases to estimate incidence of foot complications in diabetes patients 135
Utilization of antispasticity drugs in multiple sclerosis: analysis from an Italian administrative database 135
Epidemiologic and Economic Burden Attributable to First Spinal Fusion Surgery: Analysis from an Italian Administrative Database 135
Meta-analysis on incidence of inhibitors in patients with haemophilia A treated with recombinant factor VIII products 135
Health economic models in hemophilia A and utility assumptions from a clinician's perspective 132
Use of healthcare administrative databases to estimate the burden of diabaetes mellitus: a population-based study 132
Delisting of liver transplant candidates with chronic hepatitis C after viral eradication: A European study 132
Long-term costs and outcomes in psoriatic arthritis patients not responding to conventional therapy treated with tumour necrosis factor inhibitors: An extension of the Psoriatic Arthritis Cost Evaluation (PACE) study 131
Patients’, physicians’, nurses’, and pharmacists’ preferences on the characteristics of biologic agents used in the treatment of rheumatic diseases 131
Clinical epidemiology of hand eczema in patients accessing dermatological reference centres: Results from Italy 130
Measuring universal health coverage based on an index of effective coverage of health services in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 128
Use of health care administrative databases to estimate the burden of multiple sclerosis: a population-based study 126
Systematic review: economic evaluations of HCV screening in the direct-acting antivirals era 126
Utilization of disease modifying agents in multiple sclerosis: analysis from an Italian administrative database. 125
Difference in health related quality of life of chronic liver diseases and general population 125
Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 125
Antidepressants Drug Use during COVID-19 Waves in the Tuscan General Population: An Interrupted Time-Series Analysis 125
Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990-2017: A systematic analysis for the Global Burden of Disease Study 2017 124
2020 position statement and recommendations of the European Liver and Intestine Transplantation Association (ELITA): management of hepatitis B virus-related infection before and after liver transplantation 123
Thromboembolic event rate in patients exposed to anti-inhibitor coagulant complex: a meta-analysis of 40-year published data 122
Applicazione della value-based medicine nella valutazione della cura dei pazienti affetti da epatite. 122
Sofosbuvir and ribavirinin in HCV-infected patients listed for liver transplantation: A cost-effectiveness analysis 120
Impact of DAAs on liver transplantation: Major effects on the evolution of indications and results. An ELITA study based on the ELTR registry 118
Patients’ and physicians’ needs, experiences and preferences in the treatment of rght ventricular outflow tract dysfunction. 117
Cost-effectiveness of new direct-acting antivirals to prevent post-liver transplant recurrent hepatitis 116
Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 114
Totale 17.106
Salva come PNG Salva come JPEG
Categoria #
all - tutte 87.593
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 87.593
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020250 0 0 0 0 0 0 0 0 0 0 206 44
2020/20212.589 178 117 297 239 258 182 230 239 202 231 148 268
2021/20221.868 137 182 253 178 130 146 64 121 109 129 106 313
2022/20233.149 327 896 275 271 212 452 57 195 222 49 100 93
2023/20242.714 98 119 93 149 295 645 397 119 233 114 146 306
2024/20255.346 352 716 355 366 610 469 444 293 795 929 17 0
Totale 22.597